| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.07 | 0.3 |